Ibu Ratiopharm (Ibuprofen)

Ibuprofen works by reversibly inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for the synthesis of prostaglandins. By lowering prostaglandin levels, it diminishes pain signalling, reduces fever by acting on the hypothalamic thermostat, and limits the inflammatory response in tissues.

The appropriate dose of Ibu Ratiopharm is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. The prescriber will specify the exact amount, frequency, and duration of oral administration.

Ibuprofen is generally avoided during the third trimester of pregnancy because of potential fetal risks. In the first and second trimesters it may be used only when clearly needed and prescribed. Small amounts are excreted in breast milk; lactating mothers should consult a physician before using the product.

To order Ibu Ratiopharm, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then provides pricing, availability, shipping details and any necessary import documentation.

Ibu Ratiopharm contains ibuprofen, which has a relatively rapid onset of action and a moderate half‑life compared with agents such as naproxen (longer duration) or diclofenac (higher gastrointestinal risk). Its efficacy for pain, fever and inflammation is comparable, while its safety profile is typical of NSAIDs, requiring similar precautions.

Ibu Ratiopharm should be stored at room temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Ibu Ratiopharm is administered orally. The tablet should be swallowed whole with a full glass of water. It may be taken with or without food; however, taking it with meals can help lessen potential gastrointestinal discomfort.

The most serious risks include gastrointestinal bleeding or ulceration, severe renal impairment, and hypersensitivity reactions such as anaphylaxis. Patients with a history of ulcer disease, kidney dysfunction, or known allergy to NSAIDs should be monitored closely or avoid the medication.

Ibu Ratiopharm should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulcer or bleeding, severe renal or hepatic impairment, and in pregnant women during the third trimester. It should also be used with caution in patients on anticoagulants or certain antihypertensive drugs.